# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-007280
Filing Date
2020-01-14
Accepted
2020-01-14 17:00:05
Documents
9
Period of Report
2020-03-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | d864868dpre14a.htm | PRE 14A | 928189
2 | GRAPHIC | g864868g01r22.jpg | GRAPHIC | 304327
3 | GRAPHIC | g864868g02m66.jpg | GRAPHIC | 33566
4 | GRAPHIC | g864868g03z11.jpg | GRAPHIC | 99262
5 | GRAPHIC | g864868g08m78.jpg | GRAPHIC | 50524
6 | GRAPHIC | g864868g27e04.jpg | GRAPHIC | 54665
7 | GRAPHIC | g864868g70d20.jpg | GRAPHIC | 68095
8 | GRAPHIC | g864868page006.jpg | GRAPHIC | 108297
9 | GRAPHIC | g864868page007.jpg | GRAPHIC | 87881
| Complete submission text file | 0001193125-20-007280.txt |  | 2041652

Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: PRE 14A | Act: 34 | File No.: 001-38042 | Film No.: 20526524
SIC: 2834 Pharmaceutical Preparations